Research Topic · Peer-Reviewed

Chemotherapeutic Agents

Chemotherapeutic agents are pharmaceutical compounds used to treat cancer by interfering with the growth and division of malignant cells. Research published in Advanced Pharmaceutical Science And Technology addresses multiple dimensions of chemotherapeutic intervention, including emerging immunotherapy approaches th…

Curated from this journal's research 📚 8 peer-reviewed articles cited Cited 12× across the literature 🔖 ISSN 2328-0182 🗓 Reviewed July 2026

Overview

Chemotherapeutic agents are pharmaceutical compounds used to treat cancer by interfering with the growth and division of malignant cells. Research published in Advanced Pharmaceutical Science And Technology addresses multiple dimensions of chemotherapeutic intervention, including emerging immunotherapy approaches that harness the immune system to combat cancer, targeted therapies such as erlotinib for specific malignancies, and metabolic targeting strategies in hematologic cancers like chronic lymphocytic leukemia. The journal has documented clinical complications associated with chemotherapy, including vascular events in hepatocellular carcinoma patients and adverse effects of targeted agents on ocular tissues. Published work also explores complementary and alternative approaches to cancer prevention and treatment, reflecting the broader therapeutic landscape beyond conventional cytotoxic drugs. Additionally, the journal addresses critical safety considerations through research on preclinical cardiotoxicity testing models, which help identify cardiac risks before clinical deployment. Coverage extends to complex oncologic scenarios requiring advanced diagnostic techniques to distinguish treatment-related second malignancies from metastatic disease. This body of research underscores the multifaceted nature of chemotherapeutic development, from novel mechanism-based therapies to the management of treatment complications and the rigorous safety evaluation necessary for advancing cancer care.

Research published in this journal

8 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2019

Avant Garde Alleviation -Cancer Immunotherapy

Bajaj AnubhaCorresponding author
MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road , Rajouri Garden, New Delhi, 110027, India.
Exact topic Clinical and Diagnostic Pathology doi:10.14302/issn.2689-5773.jcdp-19-3061
2020

The Genetic Multiplicity- Multiple Endocrine Neoplasia type I

Bajaj AnubhaCorresponding author
MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road, Rajouri Garden, New Delhi, 110027, India.
Exact topic International Journal of Infection Prevention doi:10.14302/issn.2690-4837.ijip-20-3176
2015

Newly-Detected Solitary Bony Lytic/Sclerotic Lesion with Soft Tissue Mass in a Previously Treated Case of High-Risk Medulloblastoma: Importance of Contemporary Pathology Techniques to Differentiate Second Malignant Neoplasm from Extra-Neuraxial Metastasis 

Gupta TejpalCorresponding author
Department of Radiation Oncology, Tata Memorial Hospital (TMH) and Advanced Centre for Treatment Research & Education in Cancer (ACTREC), Tata Memorial Centre, Parel, Mumbai: 400 012, INDIA
Exact topic Brain And Spinal Cancer Cited by 1 doi:10.14302/issn.2576-182X.jbsc-14-576

How this research is being cited

The 8 articles above have been cited 12 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Chemotherapeutic Agents, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Advanced Pharmaceutical Science And Technology (ISSN 2328-0182).

Journal editorial board
natalia malara · Italy Saba Khalilpour · Italy Haseeb Khan · United States

This page summarises published research for orientation; it is not medical or professional advice.